SHANGHAI, 25 octobre 2023 /PRNewswire/ — BioRay Pharmaceutical Co. (ci-après dénommée « BioRay ») a annoncé le 7 octobre que sa demande d’essai clinique pour le BR105 Injection a reçu l’approbation de la Food and Drug Administration (FDA) des États-Unis. Il s’agit du premier projet de…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.